Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.19
P/E—
Fwd P/E16.08
PEG0.66
52W— – —
RSI—
Target$355.83 (+11.7%)
Beta0.58
Div0.72%
Loading chart…
RSI (14)
Loading patterns…
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 67
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
4Bullish
0Bearish
0Neutral
▲ Double Bottom — Two lows ~$310.78 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$265.30 — bullish reversal confirmed
▲ Bull Flag — Breakout after +9% pole — bullish continuation
▲ Bull Flag — Breakout after +12% pole — bullish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$355.83
+11.7% upside
Low $310
—
High $412
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| B of A Securities | Neutral | — | ↔ Maintain | 2026-06-24 |
| Barclays | Overweight | — | ↔ Maintain | 2026-06-10 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-05-11 |
| UBS | Buy | — | ↔ Maintain | 2026-05-07 |
| Citigroup | Buy | — | ↔ Maintain | 2026-05-07 |
| Evercore ISI Group | Outperform | — | ↔ Maintain | 2026-05-07 |
| Baird | Outperform | — | ↔ Maintain | 2026-05-07 |
| William Blair | Market Perform | — | ● Initiate | 2026-04-28 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-02-10 |
| Morgan Stanley | Overweight | Equal-Weight → Overweight | ▲ Upgrade | 2026-01-29 |
| Jefferies | Buy | Hold → Buy | ▲ Upgrade | 2026-01-22 |
| TD Cowen | Buy | — | ↔ Maintain | 2025-11-10 |
| Mizuho | Outperform | — | ↔ Maintain | 2025-11-06 |
B of A Securities
2026-06-24
Neutral
↔ Maintain
Barclays
2026-06-10
Overweight
↔ Maintain
Wells Fargo
2026-05-11
Overweight
↔ Maintain
UBS
2026-05-07
Buy
↔ Maintain
Citigroup
2026-05-07
Buy
↔ Maintain
Evercore ISI Group
2026-05-07
Outperform
↔ Maintain
Baird
2026-05-07
Outperform
↔ Maintain
William Blair
2026-04-28
Market Perform
● Initiate
JP Morgan
2026-02-10
Overweight
↔ Maintain
Morgan Stanley
2026-01-29
Overweight
(from Equal-Weight)
▲ Upgrade
Jefferies
2026-01-22
Buy
(from Hold)
▲ Upgrade
TD Cowen
2025-11-10
Buy
↔ Maintain
Mizuho
2025-11-06
Outperform
↔ Maintain
Profitability
Gross Margin
3.80%TTM
Op. Margin
1.72%TTM
ROE
107.13%TTM
Rev. Growth
3.80%YoY
Free Cash Flow
-318.25MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
420.99MRQ
Current Ratio
0.95MRQ
Cash
2.18BMRQ
Total Debt
15.09BMRQ
Net Debt
—MRQ
Income
Div. Yield
0.72%TTM
Annual Rate
2.40Fwd
Payout Ratio
17.62%TTM
Dividend History
Payout Ratio (TTM): 17.62%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-05-15 | $0.6000 | 0.23% |
| 2026-02-13 | $0.6000 | 0.17% |
| 2025-11-14 | $0.6000 | 0.17% |
| 2025-08-15 | $0.5500 | 0.19% |
| 2025-05-16 | $0.5500 | 0.19% |
| 2025-02-14 | $0.5500 | 0.23% |
| 2024-11-15 | $0.5500 | 0.23% |
| 2024-08-09 | $0.5100 | 0.22% |
| 2024-05-09 | $0.5100 | 0.23% |
| 2024-02-08 | $0.5100 | 0.23% |
| 2023-11-10 | $0.5100 | 0.26% |
| 2023-08-10 | $0.4850 | 0.27% |
| 2023-05-11 | $0.4850 | 0.29% |
| 2023-02-09 | $0.4850 | 0.32% |
| 2022-11-10 | $0.4850 | 0.32% |
| 2022-08-12 | $0.4600 | 0.32% |
| 2022-05-13 | $0.4600 | 0.31% |
| 2022-02-11 | $0.4600 | 0.34% |
| 2021-12-01 | $1.2700 | 1.16% |
| 2021-11-12 | $0.4600 | 0.39% |
| 2021-09-29 | $1.2700 | 1.10% |
| 2021-08-13 | $0.4400 | 0.39% |
| 2021-06-29 | $1.2700 | 1.19% |
| 2021-05-14 | $0.4400 | 0.41% |
| 2021-03-30 | $1.2300 | 1.13% |
| 2021-02-11 | $0.4400 | 0.46% |
| 2020-12-30 | $1.2300 | 1.41% |
| 2020-11-13 | $0.4400 | 0.46% |
| 2020-09-29 | $1.2200 | 1.43% |
| 2020-08-14 | $0.4200 | 0.46% |
| 2020-06-29 | $1.2200 | 1.41% |
| 2020-05-15 | $0.4200 | 0.57% |
| 2020-03-30 | $1.2200 | 1.61% |
| 2020-02-13 | $0.4200 | 0.53% |
| 2019-12-30 | $1.2200 | 1.73% |
| 2019-11-15 | $0.4000 | 0.55% |
| 2019-09-27 | $1.2200 | 1.83% |
| 2019-08-16 | $0.4000 | 0.56% |
| 2019-06-27 | $1.2200 | 1.76% |
| 2019-05-17 | $0.4000 | 0.65% |
How COR Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 61.99B |
| Enterprise Value | 75.09B |
| Trailing P/E | 24.51 |
| Forward P/E | 16.08 |
| PEG Ratio (5yr) | 0.66 |
| Price/Sales (ttm) | 0.19 |
| Price/Book (mrq) | 18.24 |
| EV/Revenue | 0.23 |
| EV/EBITDA | 14.17 |
Share Statistics
| Avg Vol (3m) | 1.81M |
| Shares Outstanding | 194.56M |
| Float | 184.00M |
| % Held by Insiders | 4.23% |
| % Held by Institutions | 98.97% |
| Short Ratio | 3.50 |
| Short % of Float | 3.43% |
Profitability
| Gross Margin | 3.80% |
| Operating Margin (ttm) | 1.72% |
| Profit Margin | 0.78% |
| Return on Assets (ttm) | 3.49% |
| Return on Equity (ttm) | 107.13% |
Income Statement
| Revenue (ttm) | 328.68B |
| Revenue Growth (yoy) | 3.80% |
| Gross Profit (ttm) | 12.48B |
| EBITDA | 5.30B |
| Net Income (ttm) | 2.55B |
| Diluted EPS (ttm) | 13.00 |
| EPS Growth (yoy) | 128.30% |
Balance Sheet
| Total Cash (mrq) | 2.18B |
| Total Debt (mrq) | 15.09B |
| Debt / Equity (mrq) | 420.99 |
| Current Ratio (mrq) | 0.95 |
| Book Value / Share | 17.46 |
| Operating CF (ttm) | 2.28B |
| Free Cash Flow (ttm) | -318.25M |
Trading & Dividends
| Beta (5Y) | 0.58 |
| 50-Day MA | 285.33 |
| 200-Day MA | 324.58 |
| Fwd Dividend Yield | 75.00% |
| Payout Ratio | 17.62% |
Ownership Breakdown
Institutional 98.97%
Insider 4.23%
Short Interest
3.43% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in COR in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | BATTAGLIA SILVANA | Officer | Stock Award(Grant) at price 240.53 per share. | 58 | $14,000 |
| 2026-06-30 | CAMPBELL ELIZABETH S | Officer | Stock Award(Grant) at price 240.53 per share. | 49 | $12,000 |
| 2026-06-22 | TYLER LAUREN M. | Director | Purchase at price 270.23 per share. | 550 | $148,626 |
| 2026-06-18 | DURCAN DERMOT MARK | Director | Purchase at price 274.19 per share. | 4,000 | $1,096,760 |
| 2026-05-28 | DURCAN DERMOT MARK | Director | Purchase at price 266.26 per share. | 4,000 | $1,065,040 |
| 2026-05-01 | NALLY DENNIS M | Director | Stock Award(Grant) at price 304.00 per share. | 116 | $35,264 |
| 2026-05-01 | TYLER LAUREN M. | Director | Stock Award(Grant) at price 304.00 per share. | 99 | $30,096 |
| 2026-05-01 | COOPER ELLEN | Director | Stock Award(Grant) at price 304.00 per share. | 99 | $30,096 |
| 2026-03-11 | CAMPBELL ELIZABETH S | Officer | 12,623 | — | |
| 2026-03-11 | BATTAGLIA SILVANA | Officer | 8,415 | — | |
| 2026-03-11 | CLEARY JAMES F. JR. | Chief Financial Officer | 12,623 | — | |
| 2026-03-05 | MILLER REDONDA M.D. | Director | Stock Award(Grant) at price 359.28 per share. | 557 | $200,119 |
| 2026-03-05 | NALLY DENNIS M | Director | Stock Award(Grant) at price 359.22 - 359.28 per share. | 655 | $235,323 |
| 2026-03-05 | CLYBURN FRANKLIN KING JR. | Director | Stock Award(Grant) at price 359.28 per share. | 557 | $200,119 |
| 2026-03-05 | TYLER LAUREN M. | Director | Stock Award(Grant) at price 359.22 - 359.28 per share. | 641 | $230,293 |
| 2026-03-05 | GREENBERG LON R | Director | Stock Award(Grant) at price 359.28 per share. | 557 | $200,119 |
| 2026-03-05 | DURCAN DERMOT MARK | Director | Stock Award(Grant) at price 359.28 per share. | 905 | $325,148 |
| 2026-03-05 | RYERKERK LORI J | Director | Stock Award(Grant) at price 359.28 per share. | 557 | $200,119 |
| 2026-03-05 | COOPER ELLEN | Director | Stock Award(Grant) at price 359.22 - 359.28 per share. | 692 | $248,614 |
| 2026-02-20 | MAUCH ROBERT P. | Chief Executive Officer | Conversion of Exercise of derivative security at price 86.09 per share. | 3,762 | $323,871 |
| 2026-02-20 | MAUCH ROBERT P. | Chief Executive Officer | Sale at price 358.94 per share. | 3,762 | $1,350,332 |
| 2026-02-18 | MAUCH ROBERT P. | Chief Executive Officer | Sale at price 359.46 per share. | 1,333 | $479,160 |
| 2026-01-20 | MAUCH ROBERT P. | Chief Executive Officer | Conversion of Exercise of derivative security at price 86.09 per share. | 3,763 | $323,957 |
| 2026-01-20 | MAUCH ROBERT P. | Chief Executive Officer | Sale at price 354.73 per share. | 5,096 | $1,807,704 |
| 2025-12-31 | BATTAGLIA SILVANA | Officer | Stock Award(Grant) at price 287.09 per share. | 27 | $7,850 |
BATTAGLIA SILVANA
Officer
Stock Award(Grant) at price 240.53 per share.
2026-06-30
58 sh
$14,000
CAMPBELL ELIZABETH S
Officer
Stock Award(Grant) at price 240.53 per share.
2026-06-30
49 sh
$12,000
TYLER LAUREN M.
Director
Purchase at price 270.23 per share.
2026-06-22
550 sh
$148,626
DURCAN DERMOT MARK
Director
Purchase at price 274.19 per share.
2026-06-18
4,000 sh
$1,096,760
DURCAN DERMOT MARK
Director
Purchase at price 266.26 per share.
2026-05-28
4,000 sh
$1,065,040
NALLY DENNIS M
Director
Stock Award(Grant) at price 304.00 per share.
2026-05-01
116 sh
$35,264
TYLER LAUREN M.
Director
Stock Award(Grant) at price 304.00 per share.
2026-05-01
99 sh
$30,096
COOPER ELLEN
Director
Stock Award(Grant) at price 304.00 per share.
2026-05-01
99 sh
$30,096
CAMPBELL ELIZABETH S
Officer
2026-03-11
12,623 sh
—
BATTAGLIA SILVANA
Officer
2026-03-11
8,415 sh
—
CLEARY JAMES F. JR.
Chief Financial Officer
2026-03-11
12,623 sh
—
MILLER REDONDA M.D.
Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05
557 sh
$200,119
NALLY DENNIS M
Director
Stock Award(Grant) at price 359.22 - 359.28 per share.
2026-03-05
655 sh
$235,323
CLYBURN FRANKLIN KING JR.
Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05
557 sh
$200,119
TYLER LAUREN M.
Director
Stock Award(Grant) at price 359.22 - 359.28 per share.
2026-03-05
641 sh
$230,293
GREENBERG LON R
Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05
557 sh
$200,119
DURCAN DERMOT MARK
Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05
905 sh
$325,148
RYERKERK LORI J
Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05
557 sh
$200,119
COOPER ELLEN
Director
Stock Award(Grant) at price 359.22 - 359.28 per share.
2026-03-05
692 sh
$248,614
MAUCH ROBERT P.
Chief Executive Officer
Conversion of Exercise of derivative security at price 86.09 per share.
2026-02-20
3,762 sh
$323,871
MAUCH ROBERT P.
Chief Executive Officer
Sale at price 358.94 per share.
2026-02-20
3,762 sh
$1,350,332
MAUCH ROBERT P.
Chief Executive Officer
Sale at price 359.46 per share.
2026-02-18
1,333 sh
$479,160
MAUCH ROBERT P.
Chief Executive Officer
Conversion of Exercise of derivative security at price 86.09 per share.
2026-01-20
3,763 sh
$323,957
MAUCH ROBERT P.
Chief Executive Officer
Sale at price 354.73 per share.
2026-01-20
5,096 sh
$1,807,704
BATTAGLIA SILVANA
Officer
Stock Award(Grant) at price 287.09 per share.
2025-12-31
27 sh
$7,850